June 23, 2025

Get In Touch



KGMU, CDRI Collaborate For Corona Vaccine

Lucknow: The King George's Medical University (KGMU) in Lucknow is now collaborating with the Central Drug Research Institute (CDRI) here for three major research projects, including development of a vaccine for the coronavirus.
The university, which is conducting highest number of corona tests in the state, has also been approached for the use of natural herbal products in the treatment of the disease by the Central AYUSH ministry.
According to KGMU Vice-Chancellor Prof M.L.B. Bhatt, there are at least seven research projects initiated simultaneously by the KGMU in collaboration with other scientific institutes.
"With CDRI we have three research projects - one is a molecular research to know the reasons for disease causation, second one is for finding treatment methodologies and a third project is to develop a vaccine for the virus. We have also submitted confidential proposals on novel coronavirus to the ICMR for its approval."
The KGMU is the first medical facility in the state to start convalescent plasma therapy.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!